Price$50.50-0.21 (-0.41%)
01:30 PM07:45 PM
News · 26 weeks80+200%
2026-01-182026-07-12
Mix3590d
- Insider15(43%)
- Other7(20%)
- SEC Filings6(17%)
- Analyst4(11%)
- Earnings3(9%)
Latest news
25 items- INSIDERDirector Melenikiotou Georgia was granted 344 shares, increasing direct ownership by 4% to 8,329 units (SEC Form 4)4 - Inspire Medical Systems, Inc. (0001609550) (Issuer)
- INSIDERDirector Tansey Casey M was granted 346 shares, increasing direct ownership by 1% to 26,632 units (SEC Form 4)4 - Inspire Medical Systems, Inc. (0001609550) (Issuer)
- INSIDERDirector Ellis Gary Lee was granted 581 shares, increasing direct ownership by 5% to 11,419 units (SEC Form 4)4 - Inspire Medical Systems, Inc. (0001609550) (Issuer)
- INSIDERDirector Broader Shelley G was granted 383 shares, increasing direct ownership by 5% to 8,854 units (SEC Form 4)4 - Inspire Medical Systems, Inc. (0001609550) (Issuer)
- PRCorrection: Inspire Medical Systems, Inc. to Report Second Quarter 2026 Financial Results on August 3, 2026MINNEAPOLIS, July 06, 2026 (GLOBE NEWSWIRE) -- This press release corrects the earnings release date included in the earlier version issued on July 6, 2026. No other information has changed. Inspire Medical Systems, Inc. (NYSE:INSP) (Inspire) will release financial results for the second quarter 2026 after the close of trading on Monday, August 3. Inspire’s management team will host a corresponding conference call beginning at 5:00 p.m. Eastern Time to discuss the financial results and recent business developments. A webcast of the call will be accessible via the Investor Relations page of the Inspire website or through this link: Inspire's Q2 2026 earnings call webcast. For those not pl
- PRInspire Medical Systems, Inc. to Report Second Quarter 2026 Financial Results on July 6, 2026MINNEAPOLIS, July 06, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE:INSP) (Inspire) will release financial results for the second quarter 2026 after the close of trading on Monday, August 3. Inspire’s management team will host a corresponding conference call beginning at 5:00 p.m. Eastern Time to discuss the financial results and recent business developments. A webcast of the call will be accessible via the Investor Relations page of the Inspire website or through this link: Inspire's Q2 2026 earnings call webcast. For those not planning to ask a question of management, the Company recommends listening via the webcast. If you plan to ask a question, please use the followin
- SECSEC Form SCHEDULE 13G filed by Inspire Medical Systems Inc.SCHEDULE 13G - Inspire Medical Systems, Inc. (0001609550) (Subject)
- SECInspire Medical Systems Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - Inspire Medical Systems, Inc. (0001609550) (Filer)
- ANALYSTInspire Medical Systems downgraded by Evercore ISI with a new price targetEvercore ISI downgraded Inspire Medical Systems from Outperform to In-line and set a new price target of $40.00
- PRInspire Medical Systems, Inc. Announces Presence at SLEEP 2026 and Publication of PREDICTOR StudyMINNEAPOLIS, June 16, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE:INSP), a medical technology company focused on innovative, minimally invasive solutions for patients with obstructive sleep apnea (OSA), today announced its participation in SLEEP 2026, the 40th annual meeting of the Associated Professional Sleep Societies (APSS), taking place June 14–17 in Baltimore, Maryland. SLEEP is the premier global forum for sleep medicine and research, jointly hosted by the American Academy of Sleep Medicine (AASM) and the Sleep Research Society (SRS). Advancing Innovation and Clinical Evidence "We are pleased to return to SLEEP and showcase the continued evolution of the Inspire
- PRInspire Medical Systems, Inc. to Participate in the Wells Fargo 2026 MedTech Innovation SpotlightMINNEAPOLIS, June 12, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE:INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will participate in the Wells Fargo 2026 MedTech Innovation Spotlight on Friday, June 26, 2026. Inspire is scheduled to speak at 10:00 a.m. Eastern Time. The presentation will be accessible via a live webcast here. A webcast replay of the presentation will be available for two weeks following the presentation in the Event Archive section of Inspire's Investor website at https://investors
- SECSEC Form SD filed by Inspire Medical Systems Inc.SD - Inspire Medical Systems, Inc. (0001609550) (Filer)
- ANALYSTInspire Medical Systems downgraded by BofA Securities with a new price targetBofA Securities downgraded Inspire Medical Systems from Neutral to Underperform and set a new price target of $39.00
- INSIDEROfficer Rondoni John sold $114,302 worth of shares (2,641 units at $43.28), decreasing direct ownership by 9% to 27,165 units (SEC Form 4)4 - Inspire Medical Systems, Inc. (0001609550) (Issuer)
- INSIDEROfficer Rondoni John sold $30,107 worth of shares (700 units at $43.01), decreasing direct ownership by 2% to 29,806 units (SEC Form 4)4 - Inspire Medical Systems, Inc. (0001609550) (Issuer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Inspire Medical Systems Inc.SCHEDULE 13G/A - Inspire Medical Systems, Inc. (0001609550) (Subject)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Inspire Medical Systems Inc.SCHEDULE 13G/A - Inspire Medical Systems, Inc. (0001609550) (Subject)
- INSIDERDirector Mccormick Shawn sold $31,536 worth of shares (696 units at $45.31) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 27,712 units (SEC Form 4)4 - Inspire Medical Systems, Inc. (0001609550) (Issuer)
- SECSEC Form 144 filed by Inspire Medical Systems Inc.144 - Inspire Medical Systems, Inc. (0001609550) (Subject)
- SECSEC Form S-8 filed by Inspire Medical Systems Inc.S-8 - Inspire Medical Systems, Inc. (0001609550) (Filer)
- SECInspire Medical Systems Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits8-K - Inspire Medical Systems, Inc. (0001609550) (Filer)
- ANALYSTInspire Medical Systems downgraded by Piper Sandler with a new price targetPiper Sandler downgraded Inspire Medical Systems from Overweight to Neutral and set a new price target of $55.00
- ANALYSTInspire Medical Systems downgraded by BofA Securities with a new price targetBofA Securities downgraded Inspire Medical Systems from Buy to Neutral and set a new price target of $53.00
- INSIDERDirector Ellis Gary Lee was granted 3,562 shares, increasing direct ownership by 49% to 10,838 units (SEC Form 4)4 - Inspire Medical Systems, Inc. (0001609550) (Issuer)
- INSIDERDirector Mead Dana G Jr. was granted 3,562 shares, increasing direct ownership by 16% to 26,213 units (SEC Form 4)4 - Inspire Medical Systems, Inc. (0001609550) (Issuer)
INSP FAQ
7 questionsWhat does Inspire Medical Systems Inc. do?
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and Europe. It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. The company also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. Inspire Medical Systems, Inc. was incorporated in 2007 and is...Where does INSP stock trade?
Inspire Medical Systems Inc. (INSP) is listed on NYSE.What sector and industry is INSP in?
Inspire Medical Systems Inc. operates in the Health Care sector, Medical/Dental Instruments industry.When did Inspire Medical Systems Inc. go public?
Inspire Medical Systems Inc. (INSP) completed its IPO in 2018.What are analysts saying about INSP?
Inspire Medical Systems Inc. has had 8 recent analyst actions on file. The most recent action was from Evercore ISI: In-line with a $4000.00 price target on 2026-06-23. Recent price targets range from $3900.00 to $4000.00.What companies are similar to INSP?
Notable peers in the same industry include SYK (Stryker Corporation), MMM (3M Company), BSX (Boston Scientific Corporation), MDLN (Medline Inc.), BDX (Becton Dickinson and Company). Compare INSP side-by-side with any of them on Quantisnow.How can I track INSP on Quantisnow?
Quantisnow aggregates Inspire Medical Systems Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow INSP to receive live email and push alerts on every new disclosure.